Amgen Inc. buy Royal Bank of Canada
Start price
03.04.24
/
50%
€254.85
Target price
03.04.25
€304.82
Performance (%)
8.65%
End price
04.04.25
€276.90
Summary
This prediction ended on 04.04.25 with a price of €276.90. The BUY prediction by Royal_Bank_of_Canada finished with a performance of 8.65%. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.50 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -1.185% | -1.185% | 8.681% |
| iShares Core DAX® | 1,93 % | -2,11 % | 11,14 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % | -0,15 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % | 28,83 % |
| iShares S&P 500 | -0,20 % | -3,67 % | -0,10 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $329.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten